Lercanidipin-Mepha 20 mg

Lercanidipin-Mepha is a pharmaceutical drug used primarily to treat high blood pressure (hypertension). The medication contains the active ingredient lercanidipine hydrochloride, which belongs to the class of calcium channel blockers. It is formulated to relax blood vessels, thereby improving blood flow and lowering pressure.

The Mepha brand is a well-known Swiss pharmaceutical label, originally founded in Basel in 1949. Mepha Pharma AG has established itself as a leading provider of generics in Switzerland. Ownership of the brand has transitioned through major global pharmaceutical players over the decades; it was previously part of Cephalon before being acquired by Teva Pharmaceutical Industries Ltd. in 2011. Teva, an Israeli multinational corporation, remains the ultimate owner. While the brand remains deeply rooted in Swiss operations with its headquarters in Basel, production leverages Teva's global manufacturing network, though many Swiss-market generics continue to be produced locally within Europe or Switzerland.